Clinical Trials

Studies Completed

Dr. Sher, in partnership with Peninsula Research Associates, has served as an investigator for the following clinical trials:

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow’s milk allergy

Although studies of oral immunotherapy (OIT) for food allergy have shown promise, treatment is frequently complicated by adverse reactions and, ...
Read More

The Safety of Peanut Oral Immunotherapy in Peanut-Allergic Subjects in a Single-Center Trial

Peanut allergy is the leading cause of food-related anaphylaxis, and accidental exposures are common. Oral immunotherapy (OIT) has been posited ...
Read More

Safety and feasibility of oral immunotherapy to multiple allergens for food allergy

Thirty percent of children with food allergy are allergic to more than one food. Previous studies on oral immunotherapy (OIT) ...
Read More

Oral immunotherapy for peanut allergy (PACE)

Oral immunotherapy is an emerging experimental treatment for peanut allergy, but its benefits and harms are unclear. We systematically reviewed ...
Read More

Anti-IgE treatment with oral immunotherapy in multifood allergic participants

Despite progress in single food oral immunotherapy, there is little evidence concerning the safety and efficacy of treating individuals with ...
Read More

Long-Term Follow-up of Oral Immunotherapy for Multiple Food Allergies

To report long-term follow-up data describing frequency and quantity of home dosing of food allergens following desensitization with multi-OIT protocols ...
Read More

Is a Food Allergy Looming Over You or Your Child’s Life?

“Peninsula Research Associates is conducting a clinical trial for oral immunotherapy.” ...
Read More